The Biotech Growth Trust’s (BIOG’s) highly experienced managers, Geoff Hsu and Josh Golomb, are able to draw on the considerable resources of global healthcare specialist OrbiMed. BIOG’s performance has been particularly challenging as the managers favour emerging (less mature) biotech companies, w

18 Mar 2025
Access to major innovation at low valuations

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Access to major innovation at low valuations
Biotech Growth Trust PLC (BIOG:LON) | 826 33 0.5% | Mkt Cap: 209.1m
- Published:
18 Mar 2025 -
Author:
Mel Jenner | Arron Aatkar, PhD -
Pages:
7 -
The Biotech Growth Trust’s (BIOG’s) highly experienced managers, Geoff Hsu and Josh Golomb, are able to draw on the considerable resources of global healthcare specialist OrbiMed. BIOG’s performance has been particularly challenging as the managers favour emerging (less mature) biotech companies, w